Abstract: A self-retaining surgical retractor assembly for use with a patient in a lithotomy position on a surgical table; the retractor assembly comprising a base plate positioned underneath the buttocks of a patient and base plate is held between the patient and a surface of the operating table or examination bed supporting the patient such that the retractor assembly is self-holding; self-stabilizing, and is able to maintain a fixed position relative to patient during use in an examination position while not being attached to the surgical table.

Abstract: The head stabilizer includes a suspender having a pair of bracket connectors that couple to a vehicle seat and a downwardly extending vertical positioning rod having a size and shape for select slide-on reception of a lateral support unit. The lateral support unit may be secured in a desired vertical position along the rod through locking engagement with one or more notches therein. The lateral support unit includes a pair of head pads that can be drawn in to provide side-to-side support for the user's head and a headband may couple between the pair of head pads and across the forehead to provide pitch support for the head.

Abstract: The head stabilizer includes a suspender having a pair of bracket connectors that couple to a vehicle seat and a downwardly extending vertical positioning rod having a size and shape for select slide-on reception of a lateral support unit. The lateral support unit may be secured in a desired vertical position along the rod through locking engagement with one or more notches therein. The lateral support unit includes a pair of head pads that can be drawn in to provide side-to-side support for the user's head and a headband may couple between the pair of head pads and across the forehead to provide pitch support for the head.

Abstract: The present invention relates to process for preparation of Aripiprazole with reduced particle size having dehydro impurity less than 0.1%.

Abstract: A novel process the for preparation of Indacaterol or its pharmaceutically acceptable salts and novel intermediates employed in the preparation thereof that is economically significant for large scale.

Abstract: An improved, cost effective process for the preparation of Lacosamide is disclosed. A novel intermediate of formula (IV) and a process for preparation of the novel intermediate is also disclosed. wherein, X is halogen.

Abstract: A process for the purification of Bosentan sodium and a novel crystalline form of substantially pure Bosentan sodium to disclosed in this invention.

Abstract: An improved, cost effective process for the preparation of Lacosamide is disclosed. A novel intermediate of formula (IV) and a process for preparation of the novel intermediate is also disclosed. wherein, X is halogen.

Abstract: The invention is a novel process for the preparation of lacosamide by employing novel intermediates of formula III and IV:

Abstract: Provided are novel processes for the preparation of Saxagliptin and novel intermediates employed in the process for preparing Saxagliptin.

Abstract: A novel process for the preparation of 6-perdeoxy-6-per-halo Gamma cyclodextrin which is a useful intermediate in the synthesis of Sugammadex is disclosed in the invention. The process involves reacting Gamma cyclodextrin with phosphorous halide in the presence of organic solvent.

Abstract: A process for the purification of Bosentan sodium and a novel crystalline form of substantially pure Bosentan sodium to disclosed in this invention.

Abstract: Provided are novel processes for the preparation of Saxagliptin and novel intermediates employed in the process for preparing Saxagliptin.

Abstract: An improved process for the synthesis of 3-[2-[4-((6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido[1,2-a]-pyrimidin-4-one (Paliperidone) and Paliperidone Palmitate through a novel intermediate (2-Chloroethyl)-6,7,8,9-tetrahydro-2-methyl-9-hydroxy-4H-pyrido [1,2-a]pyrimidine-4-one Palmitate ester.

Abstract: The invention provides a novel process for the synthesis of 2-(2-hydroxyphenyl)-benz[1,3]oxazin-4-one, the process comprising of reacting the salicylic acid with salicylamide in the presence of p-toluenesulfonyl chloride, base and solvent. The use of 2-(2-hydroxyphenyl)-benz[1,3]oxazin-4-one in the preparation of Deferasirox is also disclosed in the invention.

Abstract: The invention is a novel process for the preparation of lacosamide by employing novel intermediates of formula III and IV:

Abstract: The invention relates to a novel, industrially viable, cost effective process for the preparation of 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide commonly known as Rufinamide and intermediates thereof.

Abstract: A novel process for the preparation of 6-perdeoxy-6-per-halo Gamma cyclodextrin which is a useful intermediate in the synthesis of Suggamadex is disclosed in the invention. The process involves by reacting Gamma cyclodextrin with phosphorous halide in presence of organic solvent.

Abstract: An improved process for the synthesis of 3-[2-[4-((6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido[1,2-a]-pyrimidin-4-one (Paliperidone) and Paliperidone Palmitate through a novel intermediate (2-Chloroethyl)-6,7,8,9-tetrahydro-2-methyl-9-hydroxy-4H-pyrido [1,2-a]pyrimidine-4-one Palmitate ester.

Abstract: The invention provides a novel process for the synthesis of 2-(2-hydroxyphenyl)-benz[1,3]oxazin-4-one, the process comprising of reacting the salicylic acid with salicylamide in the presence of p-toluenesulfonyl chloride, base and solvent. The use of 2-(2-hydroxyphenyl)-benz[1,3]oxazin-4-one in the preparation of Deferasirox is also disclosed in the invention.